Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Pemetrexed for Lung Adenocarcinoma with Brain Metastases
NCT02284490Phase 2Unknown
- Start
- Nov 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in lung adenocarcinoma, brain metastases. Status: unknown.
02
Drugs
pemetrexed
03
Conditions
lung adenocarcinomabrain metastases
Beyond the preview
Go deeper on NCT02284490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02284490.